David Mai (he/him) is a postdoc at the Fred Hutch Cancer Center. Previously, he completed his PhD in Bioengineering at the University of Pennsylvania, where he worked on engineering therapeutic T cells for solid tumor applications. In the Srivatsan lab, David is exploring genomic technology development and its applications in cell engineering and protein design.
